Predictors of Intrahepatic Multiple Recurrences After Curative Hepatectomy for Hepatocellular Carcinoma

被引:3
|
作者
Takeishi, Kazuki [1 ,2 ,3 ]
Maeda, Takashi [2 ,3 ]
Tsujita, Eiji [2 ,3 ]
Yamashita, Yo-Ichi [1 ,2 ,3 ]
Harada, Noboru [2 ,3 ]
Itoh, Shinji [1 ]
Harimoto, Norifumi [1 ]
Ikegami, Toru [1 ]
Yoshizumi, Tomoharu [1 ]
Shirabe, Ken [1 ]
Maehara, Yoshihiko [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan
[2] Hiroshima Red Cross Hosp, Dept Surg, Hiroshima, Japan
[3] Atom Bomb Survivors Hosp, Hiroshima, Japan
关键词
Hepatocellular carcinoma; multiple recurrences; hepatectomy; PORTAL VENOUS INVASION; REPEAT HEPATECTOMY; PROGNOSTIC-FACTORS; RESECTION; EXPERIENCE; UNIVARIATE; IMPACT;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background/Aim: Survival of patients with multiple recurrences (MR) of hepatocellular carcinoma (HCC) is very poor as recurrent tumors are usually aggressive and not amenable to curative resection. The present study aimed to investigate retrospectively predictors of intrahepatic MR of HCC after hepatectomy. Patients and Methods: We reviewed 416 patients who underwent hepatectomy and developed intrahepatic recurrence during the follow-up period. According to the recurrence pattern, the patients were divided into two groups: 83 who had four or more recurrent lesions in the remnant liver were defined as the MR group and the others who constituted the control group. Results: Multivariate analysis showed that micro-intrahepatic metastasis, a-fetoprotein and tumor size were independent risk factors for MR after hepatectomy. The combination of these three independent factors was significantly associated with MR. The recurrence rates within 1 year after hepatectomy of MR and control groups were 53.0% and 27.6%, respectively (p=0.0001). The 5-year overall survival rate of the MR group was 39%, which was significantly less than that of the control group (68%, p<0.0001). Conclusions: MR of HCC was associated with an earlier recurrence and poorer survival after hepatectomy. The combination of three independent factors for MR might help predict MR occurrence during the follow-up period.
引用
收藏
页码:3061 / 3066
页数:6
相关论文
共 50 条
  • [41] Management of multiple intrahepatic recurrences after radiofrequency ablation of hepatocellular carcinoma with rhenium-188-HDD-lipiodol
    Kumar, Ajay
    Bal, Chandrasekhar
    Srivastava, Deep Narayan
    Thulkar, Sanjay Prayagraj
    Sharma, Sanjay
    Acharya, Subrato Kumar
    Duttagupta, Siddharta
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2006, 18 (02) : 219 - 223
  • [42] The prognosis of elderly patients with hepatocellular carcinoma after curative hepatectomy a multicenter competing risk analysis
    Lu, Yi
    Liang, Lei
    Lu, Wen. Feng
    Cheng, Jian
    Yao, Wei. Feng
    Xie, Ya. Ming
    Wang, Dong. Dong
    Xu, Fei. Qi
    Xiao, Zun. Qiang
    Zhang, Jun. Gang
    Liu, Jun. Wei
    Zhang, Cheng. Wu
    Huang, Dong. Sheng
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2023, 47 (07)
  • [43] Simple parameters predicting extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma
    Yoon, Jae Hyun
    Lee, Won Jae
    Kim, Sun Min
    Kim, Kwang Tack
    Cho, Sung Bum
    Kim, Hee Joon
    Ko, Yang Seok
    Kook, Hyun Yi
    Jun, Chung Hwan
    Choi, Sung Kyu
    Kim, Ban Seok
    Cho, Seo Yeon
    You, Hye-Su
    Lee, Yohan
    Son, Seyeong
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [44] Prognostic Significance of Antithrombin III Levels for Outcomes in Patients with Hepatocellular Carcinoma After Curative Hepatectomy
    Iwako, Hiroshi
    Tashiro, Hirotaka
    Amano, Hironobu
    Tanimoto, Yoshisato
    Oshita, Akihiko
    Kobayashi, Tsuyoshi
    Kuroda, Shintaro
    Tazawa, Hirofumi
    Nambu, Junko
    Mikuriya, Yoshihiro
    Abe, Tomoyuki
    Ohdan, Hideki
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (09) : 2888 - 2896
  • [45] Model to Predict Overall Survival in Patients With Hepatocellular Carcinoma After Curative Hepatectomy
    Zhang, Li-xiang
    Luo, Pan-quan
    Chen, Lei
    Song, Dong-da
    Xu, A-man
    Xu, Peng
    Xu, Jia
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [46] Survival benefit from adjuvant TACE combined with lenvatinib for patients with hepatocellular carcinoma and microvascular invasion after curative hepatectomy
    Liang, Lei
    Xu, Zhu-Ding
    Lu, Wen-Feng
    Du, Cheng-Fei
    Gao, Zhen-Yu
    Huang, Xiao-Kun
    Wang, Kai-Di
    Ye, Tai-Wei
    Dai, Mu-Gen
    Liu, Si-Yu
    Shen, Guo-Liang
    Liu, Jun-Wei
    Zhang, Cheng-Wu
    Huang, Dong-Sheng
    ASIAN JOURNAL OF SURGERY, 2024, 47 (12) : 5106 - 5112
  • [47] Adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis
    Shen, Ai
    Liu, Miao
    Zheng, Daofeng
    Chen, Qingsong
    Wu, Zhongjun
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2020, 44 (02) : 142 - 154
  • [48] Prognostic Nomograms for Patients with Hepatocellular Carcinoma After Curative Hepatectomy, with a Focus on Recurrence Timing and Post-Recurrence Management
    Xu, Wei
    Liu, Fei
    Shen, Xianbo
    Li, Ruineng
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2020, 7 : 233 - 256
  • [49] Risk factors contributing to early and date phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
    Imamura, H
    Matsuyama, Y
    Tanaka, E
    Ohkubo, T
    Hasegawa, K
    Miyagawa, S
    Sugawara, Y
    Minagawa, M
    Takayama, T
    Kawasaki, S
    Makuuchi, M
    JOURNAL OF HEPATOLOGY, 2003, 38 (02) : 200 - 207
  • [50] Predictors of Microvascular Invasion Before Hepatectomy for Hepatocellular Carcinoma
    Kaibori, Masaki
    Ishizaki, Morihiko
    Matsui, Kosuke
    Kwon, A-Hon
    JOURNAL OF SURGICAL ONCOLOGY, 2010, 102 (05) : 462 - 468